Patents by Inventor Mirko Kreh

Mirko Kreh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for the isolation of galanthamine
    Patent number: 6617452
    Abstract: The subject matter of the present invention concerns a process for the isolation of the alkaloid galanthamine; the galanthamine itself which has been produced according to this process; the use of the galanthamine thus produced in galenic preparations; and the galanthamine thus produced for treating narrow-angle glaucoma, Alzheimer's disease, as well as alcohol and nicotine dependence.
    Type: Grant
    Filed: September 12, 2002
    Date of Patent: September 9, 2003
    Assignee: LTS Lohmann Therapie-Systeme AG
    Inventors: Thomas Hille, Hans-Rainer Hoffmann, Mirko Kreh, Rudolf Matusch
  • Process for the isolation of galanthamine
    Patent number: 6573376
    Abstract: The subject matter of the present invention concerns a process for the isolation of the alkaloid galanthamine; the galanthamine itself which has been produced according to this process; the use of the galanthamine thus produced in galenic preparations; and the galanthamine thus produced for treating narrow-angle glaucoma, Alzheimer's disease, as well as alcohol and nicotine dependence.
    Type: Grant
    Filed: November 9, 2001
    Date of Patent: June 3, 2003
    Assignee: LTS Lohmann Therapie-Systeme AG
    Inventors: Thomas Hille, Hans-Rainer Hoffmann, Mirko Kreh, Rudolf Matusch
  • Process for the isolation of galanthamine
    Publication number: 20030012831
    Abstract: The subject matter of the present invention concerns a process for the isolation of the alkaloid galanthamine; the galanthamine itself which has been produced according to this process; the use of the galanthamine thus produced in galenic preparations; and the galanthamine thus produced for treating narrow-angle glaucoma, Alzheimer's disease, as well as alcohol and nicotine dependence.
    Type: Application
    Filed: September 12, 2002
    Publication date: January 16, 2003
    Inventors: Thomas Hille, Hans-Rainer Hoffmann, Mirko Kreh, Rudolf Matusch
  • Process for the isolation of galanthamine
    Publication number: 20020028802
    Abstract: The subject matter of the present invention concerns a process for the isolation of the alkaloid galanthamine; the galanthamine itself which has been produced according to this process; the use of the galanthamine thus produced in galenic preparations; and the galanthamine thus produced for treating narrow-angle glaucoma, Alzheimer's disease, as well as alcohol and nicotine dependence.
    Type: Application
    Filed: November 9, 2001
    Publication date: March 7, 2002
    Inventors: Thomas Hille, Hans-Rainer Hoffmann, Mirko Kreh, Rudolf Matusch
  • Process for the isolation of galanthamine
    Patent number: 6335328
    Abstract: The subject matter of the present invention concerns a process for the isolation of the alkaloid galanthamine; the galanthamine itself which has been produced according to this process; the use of the galanthamine thus produced in galenic preparations; and the galanthamine thus produced for treating narrow-angle glaucoma, Alzheimer's disease, as well as alcohol and nicotine dependence.
    Type: Grant
    Filed: December 21, 2000
    Date of Patent: January 1, 2002
    Assignee: LTS Lohmann Therapie-Systeme GmbH
    Inventors: Thomas Hille, Hans-Rainer Hoffmann, Mirko Kreh, Rudolf Matusch
  • Process for the isolation of galanthamine
    Publication number: 20010001100
    Abstract: The subject matter of the present invention concerns a process for the isolation of the alkaloid galanthamine; the galanthamine itself which has been produced according to this process; the use of the galanthamine thus produced in galenic preparations; and the galanthamine thus produced for treating narrow-angle glaucoma, Alzheimer's disease, as well as alcohol and nicotine dependence.
    Type: Application
    Filed: December 21, 2000
    Publication date: May 10, 2001
    Inventors: Thomas Hille, Hans-Rainer Hoffmann, Mirko Kreh, Rudolf Matusch
  • Process for the isolation of galanthamine
    Patent number: 6194404
    Abstract: The subject matter of the present invention concerns a process for the isolation of the alkaloid galanthamine; the galanthamine itself which has been produced according to this process; the use of the galanthamine thus produced in galenic preparations; and the galanthamine thus produced for treating narrow-angle glaucoma, Alzheimer's disease, as well as alcohol and nicotine dependence.
    Type: Grant
    Filed: August 7, 1998
    Date of Patent: February 27, 2001
    Assignee: LTS Lohmann Therapie-Systeme GmbH
    Inventors: Thomas Hille, Hans-Rainer Hoffmann, Mirko Kreh, Rudolf Matusch
  • Process for isolating galanthamine
    Patent number: 5877172
    Abstract: The subject matter of the present invention concerns a process for the isolation of the alkaloid galanthamine; the galanthamine itself which has been produced according to this process; the use of the galanthamine thus produced in galenic preparations; and the galanthamine thus produced for treating narrow-angle glaucoma, Alzheimer's disease, as well as alcohol and nicotine dependence.
    Type: Grant
    Filed: January 12, 1998
    Date of Patent: March 2, 1999
    Assignee: LTS Lohmann Therapie-Systeme GmbH
    Inventors: Thomas Hille, Hans-Rainer Hoffmann, Mirko Kreh, Rudolf Matusch